Details for Patent: 12,115,246
✉ Email this page to a colleague
Which drugs does patent 12,115,246 protect, and when does it expire?
Patent 12,115,246 protects EYSUVIS and INVELTYS and is included in two NDAs.
This patent has sixty-five patent family members in twelve countries.
Drugs Protected by US Patent 12,115,246
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | A METHOD FOR TREATING DRY EYE IN A PATIENT | ⤷ Subscribe | |||
| Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | A METHOD FOR THE TREATMENT OF POST-OPERATIVE INFLAMMATION FOLLOWING OCULAR SURGERY | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,115,246
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013256064 | ⤷ Subscribe | |||
| Australia | 2013256092 | ⤷ Subscribe | |||
| Australia | 2014342097 | ⤷ Subscribe | |||
| Australia | 2018201215 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
